Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

139 results about "Vitro diagnostics" patented technology

In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to ...

Functionalized magnetic microspheres, preparation method and tyrosine phosphatase antibody assay kit

The present invention belongs to the field of in vitro diagnostic technology, and discloses a functionalized magnetic microsphere, a preparation method and a tyrosine phosphatase antibody assay kit. The preparation method of the functionalized magnetic microsphere is as follows: adding silicate, active end-capping agent and magnetic bead body to a solvent and stirring and mixing evenly, heating to 60-90°C under the protection of an inert atmosphere, then dropping an acid catalyst solution for stirring reaction, filtering, washing and drying after the reaction is completed to obtain functionalized magnetic microspheres. The tyrosine phosphatase antibody assay kit includes a tyrosine phosphatase antigen-coated functionalized magnetic microsphere solution, a sheep anti-human IgG antibody fluorescent marker solution, a sample diluent, a calibration solution and a chemiluminescent substrate solution. The assay kit of the present invention can significantly improve the magnetic separation effect and detection sensitivity without the need for a biotin-streptavidin amplification system.
Owner:GUANGDONG UNITEN BIOTECHNOLOGY CO LTD

Non-invasive in-vitro method of diagnosis

The invention relates to an in-vitro method of diagnosis, prognosis, treatment response control, response prediction, of a particular human disease comprising the steps of: (i) providing for a human sample, preferably a blood sample from a subject, more preferably a plasma sample, or a serum sample or a buffy coat sample; (ii) preparing a first nucleic acid sequencing library from the nucleic acids present in said sample; (iii) hybridizing one or more TAC oligonucleotides from a first TAC oligonucleotide pool (TAC oligonucleotide-1) to said first nucleic acid library thereby isolating a first subset of library nucleic acid molecules; (iv) sequencing said first subset of library nucleic acid molecules and comparing the sequences determined to a human reference sequence, thereby creating a first group of putatively informative sequence variants (PISV 1); (v) hybridizing one or more TAC oligonucleotides from a second smaller TAC oligonucleotide pool comprising TAG oligonucleotides (TAC oligonucleotide-2) which are specific for the nucleic acid molecules of said first group of putatively informative sequence variants, to said first library of nucleic acid molecules thereby isolating a second subset of library nucleic acid molecules; (vi) sequencing said second subset of library nucleic acid molecules and comparing the sequences determined to a human reference sequence, thereby creating a second group of putatively informative sequence variants (PISV2); (vii) analyzing the putatively informative sequence variants (PISV2) thereby diagnosing, prognosing, controlling the response to a drug, for a particular human disease state. Steps (i) to (iv) are also referred to together as step A. Steps (v) to (vii) are also referred to together as step B.
Owner:MEDICOVER BIOTECH LTD

Glutamic acid determination kit and determination method

The invention provides a glutamic acid determination kit and a determination method, and belongs to the technical field of in-vitro diagnosis. The kit comprises a reagent R1 and a reagent R2, the reagent R1 is composed of a first buffer solution, 4-aminoantipyrine, glutamate oxidase, ascorbic acid enzyme, a surfactant, a stabilizer and a preservative, and the reagent R2 is composed of a second buffer solution, a chromogenic substrate, peroxidase and a preservative. The preparation process of the kit is simple, the raw materials are easy to purchase, and the determination method using the kit has the advantages of being independent of large instruments, simple to operate, short in detection time, high in accuracy, good in precision and good in stability, is suitable for base layer detection, large-scale sample batch detection and the like, and has good application prospects.
Owner:WUHAN LIFE ORIGIN BIOTECH LTD

Serum metabolism fingerprint extraction method and application

The invention discloses an extraction method and application of a serum metabolism fingerprint spectrum. According to the method, an iron-cobalt bimetallic oxide material is combined with laser desorption / ionization mass spectrometry, a metabolic fingerprint spectrum in serum is extracted, feature extraction and normalization are carried out, and a chronic obstructive pulmonary disease patient and a healthy person are distinguished in combination with a machine learning algorithm. The iron-cobalt bimetallic oxide material has strong ultraviolet absorption and high desorption / ionization efficiency, and can efficiently absorb mass spectrum laser energy and transfer the mass spectrum laser energy to metabolites to ionize the metabolites. By means of the method, the metabolic fingerprint spectrum of the serum sample can be obtained more rapidly, more simply and more conveniently in a high-throughput mode, rapid in-vitro diagnosis of the chronic obstructive pulmonary disease is successfully achieved in combination with a machine learning algorithm, high sensitivity and high accuracy are achieved, and the method has huge potential in the aspects of large-scale disease diagnosis and screening.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

A method for correcting fluorescence images to obtain amplification fluorescence results and an amplification detection system

ActiveCN117965703BEfficient and accurate fittingReduce the effects of noiseImage enhancementBioreactor/fermenter combinationsFluorescenceReference image
The present invention belongs to the field of in vitro diagnostic technology, and particularly relates to a method for correcting fluorescence images to obtain amplification fluorescence results and an amplification detection system. The technical scheme is: a method for correcting fluorescence images to obtain amplification fluorescence results, an array optical detector obtains multiple fluorescence images at different times during the amplification process, and obtains a saturation / null value binary state associated image from at least one of the fluorescence images based on a first threshold value, and calculates at least one of the fluorescence images and the associated image using a first calculation method to obtain a corrected amplification reference image, and divides the amplification reference image into multiple ROI areas using a segmentation algorithm, and calculates all pixel values ​​of each ROI area of ​​the amplification reference image using a second calculation method, and uses all pixel values ​​of each ROI area as the amplification fluorescence result reference value of at least one of the fluorescence images at the corresponding moment. The present invention provides a method for correcting fluorescence images to obtain amplification fluorescence results and an amplification detection system.
Owner:XIAN TIANLONG SCI & TECH

Reaction cup arranging device and cup arranging control method

The invention discloses a reaction cup arranging device and a cup arranging control method. The cup arranging device comprises a material groove, a conveying belt, a cup fishing mechanism, a cup hitting mechanism, a vertical cache channel, a cup placing mechanism, a rotary cache mechanism and a control module. According to the cup arranging control method, a first part state machine and a second part state machine are included, the first part state machine is used for converting reaction cups in an unordered state into reaction cups in an ordered state to be output, and the second part state machine is used for outputting the reaction cups in the ordered state to other devices. According to the cup arranging device and the cup arranging control method, the reaction cups can be continuously, timely and efficiently supplemented, the operation performance and the automation level of in-vitro diagnosis equipment can be remarkably improved, and the problems that in an existing cup arranging system, the reaction cups are not supplemented in time, operation is not synchronous, and fault processing is complex are solved; and the operation efficiency of the equipment and the detection continuity are improved.
Owner:GUANGZHOU KEFEN BIOTECH CO LTD

An integrated robot automatic latex particle ultrasonic dispersion device

The application discloses a kind of integrated robot latex particle automatic ultrasonic dispersion equipment, including rack, quick-change head device, workpiece fixture rack, ultrasonic water bath and robot;Workpiece fixture rack is equipped with transfer clamp and placement slot, and the movable end of robot is equipped with clamp joint;Robot can drive clamp joint to butt joint or release quick-change head device, and drive quick-change head device to carry out secondary pressing positioning to sample bottle in placement slot;Robot can drive clamp joint to butt joint or release the transfer clamp of workpiece fixture rack, and robot can drive workpiece fixture rack and sample bottle thereon to carry out multidimensional composite motion in ultrasonic water bath.The equipment can realize the semi-automatic linkage operation of "feeding-positioning-ultrasonic dispersion-discharging", reduce manual intervention, guarantee the stability and consistency of latex particle dispersion in sample bottle in large-scale mass production process, significantly improve production efficiency and product quality, and provide key technical support for process upgrading of in-vitro diagnosis industry.
Owner:RUNBIO BIOTECH CO LTD

RPA primer pair for absolute quantification of pseudomonas aeruginosa, double crRNA and kit

The invention discloses an RPA primer pair for absolute quantification of pseudomonas aeruginosa, double crRNA and a kit, and belongs to the fields of biology, detection and in-vitro diagnosis. The RPA primer pair provided by the invention is screened and designed for specific genes of pseudomonas aeruginosa, and can amplify target gene segments. The double crRNA is crRNA1 and crRNA2, and both the crRNA1 and the crRNA2 can specifically recognize corresponding target gene segments. The RPA primer pair, the double crRNA and the kit provided by the invention can realize absolute quantitative detection of pseudomonas aeruginosa, and have the characteristics of low cost (no need of expensive instruments, high sensitivity and the like); a portable constant-temperature fluorescence detector is adopted), the operation is simple and convenient (only 37 DEG C reaction is needed), the efficiency is high (the detection time is less than 1 hour), the sensitivity is high (the minimum is 10CFU), the resolution ratio is high (the quantification of the seed level is realized), a standard curve is linearly fitted based on inflection points, the accuracy is high (R2 is greater than 0.99), and the like.
Owner:JIANGNAN UNIV

Antibodies to novel bunyaviruses and uses thereof

The present application relates to the technical field of in vitro diagnosis, in particular to antibodies of new bunyavirus and application thereof. The present application provides antibodies of new bunyavirus and application thereof. The antibodies of new bunyavirus screened by the present application can specifically bind to new bunyavirus of different mutation types, have high sensitivity and strong specificity, and have good market application prospect. The detection sensitivity of SFTSV is determined by using a double-antibody sandwich method, and the results show that the antibodies of new bunyavirus provided by the present application have a detection sensitivity as low as 0.5 ng / mL, and can be used for early diagnosis and detection of SFTSV.
Owner:ZHENGZHOU IMMUNO BIOTECH

LC-MS / MS-based TAR DNA binding protein 43 detection method and application

The invention belongs to the technical field of biomedical detection, and discloses a TAR DNA binding protein 43 detection method based on LC-MS / MS and application. The detection method comprises the following steps: taking a biological matrix to be detected, and filtering to obtain filtrate; adding an ion enhancer into the obtained filtrate, oscillating and incubating, adding a protein precipitant, and separating precipitated protein; adding trypsin into the precipitated protein, and incubating to obtain a sample containing a characteristic peptide fragment; and detecting the TAR DNA binding protein 43 in the sample by adopting liquid chromatography-triple quadrupole mass spectrometry. According to the method, the TDP-43 is specifically detected and quantified by adopting a liquid chromatography-tandem mass spectrometry technology, so that the excellent effects of efficiently detecting and accurately quantifying the TDP-43 and improving the detection sensitivity and stability are achieved. The method can be applied to the fields of in-vitro diagnosis of neurodegenerative diseases, pathological mechanism research and therapeutic drug development.
Owner:THE GBA NAT INST FOR NANOTECHNOLOGY INNOVATION

Monoclonal antibodies to eosinophil peroxidase and uses thereof

The present application relates to the field of biotechnology and in vitro diagnosis, and relates to a monoclonal antibody of eosinophil peroxidase and application thereof. The antibody of the present application is mainly used for detecting the content of eosinophil peroxidase by western blot. The monoclonal antibody of eosinophil peroxidase of the present application is prepared by immunizing Balb / c mice with recombinant eosinophil peroxidase as an immunogen, then fusing the spleen with myeloma cells NS1, and screening and purifying. The prepared monoclonal antibody of eosinophil peroxidase specifically recognizes the linear epitope of eosinophil peroxidase.
Owner:AUTOBIO DIAGNOSTICS CO LTD

Light measuring device for chemiluminescence instrument

The invention provides a photometric device for a chemiluminescence instrument, and belongs to the technical field of in-vitro diagnosis. The device comprises a mounting base, a light shading unit is fixedly mounted on the mounting base, a light metering piece is fixedly connected to the light shading unit through a light metering fixing piece, a supporting plate is fixedly mounted on the mounting base, a light metering counter is fixedly mounted on the supporting plate, and a light shading piece controlled by a transmission mechanism is slidably mounted in the light shading unit. A cup placing hole is formed in the shading piece, and a reaction cup is placed in the cup placing hole. According to the scheme, the received photon signals are converted into the electric signals through the photometric piece and transmitted to the photometric counter, the photometric counter carries out quantization processing on the electric signals, precise detection of the luminous intensity is achieved, through the design of the integrated cassette, light leakage and signal loss are reduced, the detection sensitivity and the data accuracy are remarkably improved, and the detection accuracy is improved. Meanwhile, the structural layout is simplified, and a foundation is laid for device miniaturization.
Owner:JIANGSU AOYA BIOTECHNOLOGY CO LTD

A method for in vitro diagnosis of multiple sclerosis

PCT designated stage expiredWO2024248642A1Disease diagnosisPeripheral blood mononuclear cellMyelin
The invention concerns a method for in vitro diagnosis of multiple sclerosis (MS ) based on the absolute count of lymphocytes with the CD49d+CD154+ phenotype autoreactive toward myelin proteins after the exposure of Peripheral Blood Mononuclear Cells to myelin peptides in the in vitro conditions. The method is useful for the early diagnosis of multiple sclerosis.
Owner:UNIV MEDYCZNY W ODZI

B-type natriuretic peptide stabilizer as well as preparation method and application thereof

The invention discloses a B-type natriuretic peptide stabilizer as well as a preparation method and application thereof. The stabilizer is prepared from the following components: 10 to 90 v / v percent of human serum matrix, 5 to 25 g / L of trehalose, 10 to 25 g / L of mannitol, 1 to 5 mM of N-acetylcysteine, 1.0 to 2.5 g / L of fish gelatin, 0.02 to 0.1 v / v percent of preservative and 0.02 to 0.1 v / v percent of 5-bromo-5-nitro-1, 3-dioxane. The stabilizer can improve the stability of the B-type natriuretic peptide BNP in the serum-containing stabilizer, greatly improves the storage stability, effectively prolongs the shelf life of an independent quality control product for in-vitro diagnosis, and improves the commercial value; and meanwhile, the qualitative change resistance in the preparation and storage processes is improved, and the batch-to-batch difference caused by a freeze-drying process is reduced.
Owner:GENEWELL BIOTECHNOLOGY CO LTD

Use of a donor agent in the diagnosis of myocardial injury in a subject

The present application relates to a kind of donor reagent in the preparation for the use of kit for the method for diagnosing whether subject is suffered from myocardial injury in vitro, wherein the method comprises: the body fluid from subject is contacted with acceptor reagent and donor reagent, and generates to be measured mixture after reaction;The intensity of signal of chemiluminescence thus produced is detected by exciting the to-be-measured mixture at least once with excitation light;The concentration of at least one myocardial marker in the body fluid is quantitatively calculated according to the intensity of signal of chemiluminescence, to determine whether subject is suffered from myocardial injury;Wherein, the donor reagent includes donor particles capable of generating active oxygen in excited state, and the particle size distribution of the donor particles in the donor reagent presents polydispersity;The surface of the first carrier is not coated or connected with polysaccharide substance, and is directly chemically bonded with one of specific binding pairing members.The method has both ultra-high sensitivity and very wide detection range.
Owner:BEYOND DIAGNOSTICS (SHANGHAI) CO LTD +1

Method for the in vitro diagnosis of a neurodegenerative disease

PCT designated stage expiredWO2024231628A1Compound screeningApoptosis detectionAmyloid betaFibril
The invention relates to a method for the early in vitro diagnosis of a neurodegenerative disease in a human or an animal subject, the method comprising the step of detecting the presence of at least one marker chosen from among forms derived from amyloid beta peptides (Aβ) chosen from among the oligomers of these peptides and the prefibrillar and fibrillar aggregate forms of these peptides, and forms derived from phosphorylated tau proteins chosen from among the hyperphosphorylated forms of these proteins, the aggregate forms of these proteins and the modified phosphorylated tau proteins resulting from one or more post-translational modifications, the presence of the one or more markers being detected in a stool sample from this subject.
Owner:UNIVERSITE GRENOBLE ALPES +1

Nondestructive testing system and method for calibrating response performance of cold air thruster

The invention relates to a nondestructive testing system and method for calibrating response performance of a cold air thruster, in the system, an air inlet of a stop valve is connected to an external air source, an air outlet of the stop valve is connected to an air inlet of a pressure reducing valve, and an air outlet of the pressure reducing valve is connected to an air inlet of a first pressure sensor; an air outlet of the first pressure sensor is connected to an air inlet of the first sealing device, an air outlet of the first sealing device is connected to an air inlet of the cold air thruster, and a nozzle of the cold air thruster is connected to the gas collector through the second sealing device; the vacuum pump is connected to the gas collector through a metal hose, the vacuum pump is started before detection, gas in the gas collector is pumped out, and a vacuum environment needed by work of the cold air thruster is established. An in-vitro diagnostic detection method is adopted, local gas pressure changes are measured, the dynamic response time of the cold air thruster is calibrated, the detection efficiency is improved through a standardized sealing interface design, and operation is convenient and reliable.
Owner:BEIJING INST OF CONTROL ENG

Method of storing latex particle dispersion liquid

To provide a novel technique with which the generation of aggregates over time in a dispersion liquid can be suppressed and a target substance can be detected with high sensitivity even if latex particles that have been stored are used. A method for storing in a container a latex particle dispersion liquid in which latex particles for an extracorporeal diagnostic agent are dispersed, the latex particles having a volume average particle size of 10 to 1000 nm and including a polymer containing 70 to 100% by mass of monomer units each derived from a monomer having an aryl group relative to the total monomer units, which is characterized in that the particle dispersion liquid is stored in the container by setting a ratio of a volume of a void space obtained by excluding a volume occupied by the particle dispersion liquid from an internal volume of the container to 0 to 25% (v / v) relative to the internal volume of the container.
Owner:JSR LIFE SCIENCES LLC +3

Colon cancer biomarkers

The present invention provides a method for the diagnosis in vitro of colon cancer in a subject that comprises (i) determining in a sample isolated from the subject the expression level of at least one gene selected from the list consisting of LNC-TBP-2, CCL5, DENND2B, LRRC52-AS1, and RNF31, (ii) calculating a variable S, wherein S= A +B + C – D – E, and wherein: A is the expression level of gene LNC-TBP-2 when the expression level of gene LNC-TBP-2 is determined in step (i), or is 0 when the expression level of gene LNC-TBP-2 is not determined in step (i); B is the expression level of gene CCL5 when the expression level of gene CCL5 is determined in step (i), or is 0 when the expression level of gene CCL5 is not determined in step (i); C is the expression level of gene DENND2B when the expression level of gene DENND2B is determined in step (i), or is 0 when the expression level of gene DENND2B is not determined in step (i); D is the expression level of gene LRRC52-AS1 when the expression level of gene LRRC52-AS1 is determined in step (i), or 0 when the expression level of gene LRRC52-AS1 is not determined in step (i); and E is the expression level of gene RNF31 when the expression level of gene RNF31 is determined in step (i), or is 0 when the expression level of gene RNF31 is not determined in step (i); and (iii) diagnosing the subject as having colon cancer if S calculated in step (ii) is equal or lower than a corresponding reference value. The present invention also provides the use of LNC-TBP-2, CCL5, DENND2B, LRRC52-AS1, and RNF31 as biomarkers of CRC.
Owner:FLOMICS BIOTECH SL

Method for the in vitro diagnosis of cardiovascular disease

The present invention relates to a method for the in vitro diagnosis of cardiovascular disease or physiopathological state by detecting, quantifying and characterising biomarkers of membrane proteins linked to extracellular vesicles present in blood plasma. The method provides the quantification of extracellular vesicles containing the hERG1 protein and / or Hsp47 protein.
Owner:UNIV DE LOS ANDES +1

Recyclable cleaning fluid supply system and method and sample analyzer

The invention relates to the technical field of in-vitro diagnosis, and particularly discloses a recyclable cleaning fluid supply system and method. Comprising a second cleaning liquid barrel storing second cleaning liquid and provided with a first pipeline, a first three-way valve connected with the first pipeline, a second three-way valve, a third three-way valve, a plunger pump located between the second three-way valve and the third three-way valve and connected with the second three-way valve and the third three-way valve, and a two-way valve connected with the third three-way valve. The needle washing pool is connected with the two-way valve; the top of a pump head in the plunger pump is connected with a third three-way valve, and the bottom of the pump head in the plunger pump is connected with a second three-way valve. A connecting pipeline among the liquid inlet end of the needle washing pool, the two-way valve, the three-way valve III and the plunger pump forms a second cleaning liquid flow path; the second cleaning solution is an alkaline or acidic cleaning solution. Recycling and cleaning maintenance of the second cleaning liquid can be achieved, the inspection cost of the analytical instrument is reduced, and meanwhile the workload of instrument operators is reduced.
Owner:MACCURA MEDICAL INSTR CO LTD +1

Feeding slideway structure and test analyzer

The invention relates to the technical field of in-vitro diagnosis automation equipment, and discloses a feeding slideway structure and a test analyzer, and the feeding slideway structure comprises a blanking hopper which is provided with a feeding end and a discharging end; and the slideway is arranged at the discharging end and partially extends into the blanking hopper. The bearing piece is arranged at the part, extending into the blanking hopper, of the slide way and is positioned at the falling point position after the reaction cup enters the blanking hopper. The cup shifting structure comprises a shifting piece located above the sliding way, one end of the shifting piece is rotatably arranged close to the discharging end, the other end of the shifting piece extends in the direction of the sliding way, and the shifting piece is used for correcting the posture of the reaction cup entering the sliding way. According to the feeding sliding way structure, the correction efficiency of the reaction cups is improved through the bearing pieces, the time for the reaction cups to pass through the discharging hopper is shortened, the feeding requirement of high-speed equipment for the reaction cups can be met, the probability of cup stacking and cup clamping is reduced, and faults caused by cup punching can be prevented through the stirring pieces.
Owner:SHENZHEN LINKRAY BIOTECH CO LTD

Instrument for automatic detection of electrochemical sensor

InactiveCN119291221Aavoid cross contaminationImprove liquid adding and pipetting efficiencyMaterial analysisControl systemVitro diagnostics
The invention relates to the field of in-vitro diagnosis, in particular to an automatic detection instrument for an electrochemical sensor, which comprises a vertical electric sliding table provided with a sensor kit fixing sliding block, a first XZ combined electric sliding table provided with an electrode fixing sliding block, an electrode cleaning device and a second XZ combined electric sliding table provided with a liquid suction head fixing sliding block, the horizontal electric sliding table is provided with an injector push rod fixing sliding block and an injector body fixing block, and the injector is provided with a three-way valve; the invention provides an instrument for automatic detection of an electrochemical sensor, which can realize sampling tube taking and placing, electrode cleaning, rapid sample injection and sampling detection, avoid cross contamination, improve the detection accuracy, facilitate sample feeding and result output, and is simple to operate and high in automation degree.
Owner:T J BIOTECH TIANJIN

A monoclonal antibody against IGF-1, preparation method, kit and application thereof

The present invention discloses an anti-IGF-1 monoclonal antibody, a preparation method, a kit and an application thereof, wherein the monoclonal antibody is selected from any one of the following groups: the first group: the heavy chain variable region amino acid sequence SEQ ID NO.1 and the light chain variable region amino acid sequence SEQ ID NO.2; the second group: the heavy chain variable region amino acid sequence SEQ ID NO.3 and the light chain variable region amino acid sequence SEQ ID NO.4. The anti-IGF-1 monoclonal antibody and the amino acid sequences of the heavy chain variable region and the light chain variable region thereof are disclosed. A preparation method of the anti-IGF-1 monoclonal antibody is designed. The monoclonal antibody is used in a detection kit and in the preparation of a drug for diagnosing or treating a malignant tumor with abnormal expression of IGF-1. The monoclonal antibody has strong affinity and stability and can be used as a high-quality diagnostic raw material for in vitro diagnosis.
Owner:JIANGSU KEYGEN BIOTECH CORP LTD

Full-automatic immunohistochemical staining and sealing integrated machine

PendingCN122448602AStainingVitro diagnostics
The present application belongs to the pathological diagnosis technical field in vitro diagnosis, technical field, automatic dyeing, automatic sealing is integrated into a whole automatic immunohistochemical dye sealing integrated machine. The automatic immunohistochemical dye sealing integrated machine is used for dyeing and sealing treatment of the glass slide with tissue, comprising a shell, a rack, a dyeing device, a sealing device, a sample loading device, a transfer device and a control device, the dyeing device, the sealing device, the sample loading device and the transfer device are all arranged on the rack and are all electrically connected with the control device, covered by the shell, the dyeing device, the sealing device and the sample loading device are arranged in different regions, the transfer device is movably arranged above the dyeing device, the sealing device and the sample loading device, the dyeing device comprises a dyeing module and a reagent module, and the sealing device comprises a sealing module and a slide cleaning module.
Owner:JIAXING QUEST LIFE SCI

Particle for immunoagglutination assay and test reagent for in vitro diagnosis

There is provided a particle for the immunoagglutination assay that is a particle for immunoagglutination assay, which includes a diamond particle and a ligand that specifically binds to a biological substance. The ligand is immobilized to the diamond particle, and the particle for the immunoagglutination assay has a particle size of 50 nm or more and 1,000 nm or less.
Owner:CANON KK

Composition, kit, and method for detecting large-size ctnitc, and use thereof

The present application relates to a composition, kit, and method for detecting a large-size cTnITC, and a use thereof. Specifically, the present application relates to a composition and kit containing an antibody specifically binding to any segment of an amino acid sequence of cTnT from position 67 to position 222 and an antibody specifically binding to any segment of an amino acid sequence of TnC, a detection method, and a use in vitro diagnosis of myocardial injury.
Owner:SHENZHEN MINDRAY BIO MEDICAL ELECTRONICS CO LTD

Anti-African horse pestivirus VP7 protein murine recombinant antibody and preparation method thereof

The invention belongs to the technical field of in-vitro diagnosis, and particularly relates to a mouse recombinant antibody for resisting African horse pestivirus VP7 protein and a preparation method of the mouse recombinant antibody. The method comprises the following steps: screening a hybridoma cell strain 2B8 aiming at African horse pestivirus VP7 protein by using a hybridoma cell technology, splitting the hybridoma cell strain 2B8 by using Trizol, extracting total RNA (Ribonucleic Acid), and amplifying by using a nested PCR (Polymerase Chain Reaction) method to obtain heavy chain and light chain variable region sequences; the heavy chain and light chain variable region sequences are constructed on a vector containing a murine source constant region, and the recombinant antibody for resisting the African horse pestivirus VP7 protein is successfully expressed and obtained; the recombinant antibody can recognize recombinant VP7 protein expressed by escherichia coli and is subjected to specific reaction with the recombinant VP7 protein expressed in a BHK21 cell; the recombinant antibody can be used for establishing an African horse pestivirus competitive ELISA antibody detection method, and a technical basis is provided for effectively preventing and controlling African horse pestivirus from entering China.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Composite material of core-shell structure nano material loaded with precious metal nano enzyme as well as preparation method and application of composite material

The invention relates to the technical field of precious metal composite materials, and discloses a composite material with a core-shell structure nanometer material loaded with precious metal nanometer enzyme and a preparation method and application thereof.The preparation method of the material comprises the steps that Au NPs is prepared, specifically, pure water is kept at 100 DEG C for backflow, chloroauric acid is added, sodium citrate is added after boiling is conducted again, and after the reaction is completed, Au NPs is obtained; cooling, centrifuging, washing and resuspending; au NPs modification: dispersing Au NPs in a stabilizer solution, stirring for reaction, centrifugally washing, and resuspending; the preparation method comprises the following steps: adding ammonia water into an Au-coated SiO2: Au ethanol solution, adding TEOS (Tetraethyl Orthosilicate) in a water bath at 30 DEG C for reaction, centrifugally washing, and Preparing Au-coated SiO2-COOH: adjusting the pH value of the Au-coated SiO2 solution, then adding a carboxyl ethyl silanetriol sodium salt solution for reaction, and carrying out centrifugal washing to obtain Au-coated SiO2-COOH; the preparation method comprises the following steps: preparing Au-coated SiO2-COOH-coated NMN: carrying out ultrasonic treatment on Au-coated SiO2-COOH dispersion liquid, adding a noble metal precursor solution, carrying out ice-water bath, adding NaBH4, carrying out a reaction, carrying out centrifugal washing, and re-suspending in pure water to obtain the Au-coated SiO2-COOH-coated NMN. The composite material disclosed by the invention has good chemical stability and good biocompatibility in a complex environment, and can lay a foundation for application in the fields of in-vitro diagnosis, biological catalysis and the like.
Owner:CHONGQING KANGJU QUANHONG BIOTECHNOLOGY CO

Metabolic marker combination for kidney cancer diagnosis or auxiliary diagnosis and application thereof

The invention provides a metabolic marker combination for diagnosis or auxiliary diagnosis of kidney cancer and application of the metabolic marker combination, and belongs to the technical field of in-vitro diagnosis. The invention provides a metabolic marker combination for diagnosis or auxiliary diagnosis of kidney cancer. The metabolic marker combination comprises L-glucan and aspartic acid, the metabolism marker comprises a blood metabolism marker or a urine metabolism marker. The diagnosis model for distinguishing healthy individuals and kidney cancer patients is constructed by adopting L-glucan and aspartic acid, so that the diagnosis efficiency is high, and the clinical diagnosis significance is realized. In addition, 12 metabolic markers, 10 metabolic markers, 8 metabolic markers, 6 metabolic markers and 4 metabolic markers containing L-glucan and aspartic acid are respectively subjected to construction of diagnosis models for distinguishing healthy individuals from kidney cancer patients, and the constructed diagnosis models have relatively high diagnosis efficiency; the clinical diagnosis significance is realized.
Owner:HARBIN METANOTITIA INC